Sequenom Inc (SQNM)

2.39
0.01 0.42
NASDAQ : Health Care
Prev Close 2.40
Open 2.39
Day Low/High 2.39 / 2.40
52 Wk Low/High 0.00 / 0.00
Volume 2.05M
Avg Volume 2.19M
Exchange NASDAQ
Shares Outstanding 119.24M
Market Cap 284.99M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Sequenom Stock Falls On Unusually High Volume (SQNM)

Sequenom Stock Falls On Unusually High Volume (SQNM)

Sequenom (Nasdaq:SQNM) is trading at unusually high volume Tuesday with 8.7 million shares changing hands. It is currently at 4 times its average daily volume and trading down 30 cents (-4.4%).

Sequenom, Clearwire: Small-Cap Winners

Sequenom, Clearwire: Small-Cap Winners

TheStreet presents a rundown of the winners in the small-cap space during the day's trading.

"Just Don't Fail", Spotting Investment Scams, Pernix CEO

"Just Don't Fail", Spotting Investment Scams, Pernix CEO

Guests include Josh Sundquist, author of "Just Don't Fail", Ken Springer, author of "Digging for Disclosure" and Cooper Collins, CEO of Pernix Therapeutics.

Aeropostale, Sequenom: After-Hours Trades

Aeropostale, Sequenom: After-Hours Trades

Shares of Aeropostale were down in late trades on news of a weak outlook and a management shake-up.

Sequenom CEO Discusses Q3 2010 - Earnings Call Transcript

Sequenom CEO Discusses Q3 2010 - Earnings Call Transcript

Sequenom CEO Discusses Q3 2010 - Earnings Call Transcript

Sequenom Announces Date Of Third Quarter 2010 Financial Results And Conference Call

Sequenom, Inc. (NASDAQ: SQNM), will report third quarter 2010 financial results after market close on Thursday, November 4, 2010.

Biotech Stock Mailbag: Exact Sciences

Biotech columnist Adam Feuerstein answers readers' questions about drug and health care-related firms.

Biotech Stock Mailbag: Generex

Biotech columnist Adam Feuerstein answers readers' questions about drug and health care-related firms.

Stock Offerings: Center Bancorp

Stock Offerings: Center Bancorp

Center Bancorp prices two concurrent offerings of common stock.

Sequenom, Inc. Q2 2010 Earnings Call Transcript

Sequenom, Inc. Q2 2010 Earnings Call Transcript

'Mad Money Lightning Round': No on Best Buy

Cramer says he doesn't see a bottom to this company, despite a recent dividend boost.

Cramer's 'Mad Money' Recap: Don't Bank on Cheap Stocks (Final)

Cramer says an activist, anti-business federal government is sending earnings and stocks lower.

Wendy's/Arby's, Mad Catz: Early Volume Plays

Several stocks trading near $5, including Wendy's/Arby's, were poised to move on above-average volume Friday.

Past Sequenom Exec Charged with Lying by SEC

Sequenom's R&D chief manipulated and lied about data pertaining to company's gene test for Down's syndrome, alleges SEC.

Stock Offerings: Sequenom

Sequenom announced a $51.6 million private placement.

Trico Marine Services, Sequenom: Early Volume Plays

Trico Marine Service was one of several stocks trading near $5 poised to move on above-average volume Friday.

Biotech Calendar: Key Dates for May

Here's a list of May's potentially stock-moving biotech events.

JA Solar, Blockbuster: Early Volume Plays

Several stocks trading near $5 were moving on above-average volume during Wednesday's session.

Sequenom, Digital Ally: Midday Volume Plays

Several stocks trading near $5 were moving on above-average volume during Tuesday's session.

Biotech Stock Mailbag: Generex

Columnist Feuerstein talks about alternative insulin-delivery devices and answers readers' questions about Generex and other biotech firms.

Sequenom Fails to Match Hype

Disappointed investors sell Sequenom after the company offers a conservative outlook for 2010 and says cash needs to be raised.

Icagen, Sequenom: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.

Cramer's 'Mad Money' Follow-Up: March 15

Here's how some of Friday's 'Mad Money' stocks fared on Monday.

Biotech Stock Mailbag: Sequenom

Biotech watcher Adam Feuerstein answers readers' questions about Sequenom and other health care-related firms.

'Mad Money' Recap: Apple Riding High With the iPad (Final)

Cramer is convinced the success of the iPad among consumers and companies will lift Apple shares higher.

'Mad Money Lightning Round': TiVo Clicks

Cramer says to buy the stock on the pullback

Sequenom Mania Fueled By Fuzzy Math: BioBuzz

Sequenom Mania Fueled By Fuzzy Math: BioBuzz

Cantor Fitzgerald's upgrade of Sequenom doesn't add up.

Cyclacel, Netlist: Early Volume Plays

A handful of stocks trading near $5 were poised to move on above-average volume during Wednesday's regular session.

Brocade, Rigel, ARM: Early Volume Plays

Brocade, Rigel, ARM: Early Volume Plays

Several stocks trading under $10 were poised to move on above-average volume during Tuesday's session.

Biotech Stock Mailbag: NexMed

Biotech Stock Mailbag: NexMed

Biotech watchdog Adam Feuerstein answers readers' questions about NexMed, Cell Therapeutics and other news-worthy stocks.